SCHEMBL8967183

SCHEMBL8967183

BC(I)I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10016147 0.83
SCHEMBL18306916 0.72
SCHEMBL13792671 0.72
SCHEMBL2055282 0.72
SCHEMBL15003922 0.72
SCHEMBL4546305 0.61
SCHEMBL333801 0.58
SCHEMBL6747842 0.55
Iodoform SCHEMBL28140705 0.55
Iodoform SCHEMBL27906049 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180215740-A1 PARA-SUBSTITUTED INDANYL AND TETRALINYL DERIVATIVES BASF SE (DE) 2018-08-02 US disclosed
US-20180022704-A1 PROCESS FOR THE PREPARATION OF HISTAMINE H3 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-01-25 US disclosed
US-9809547-B2 Process for the preparation of histamine H3 receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2017-11-07 US disclosed
US-20170057919-A1 PROCESS FOR THE PREPARATION OF HISTAMINE H3 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2017-03-02 US disclosed
US-9518021-B2 Process for the preparation of histamine H3 receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2016-12-13 US disclosed
US-9187408-B2 Process for the preparation of protected L-alanine derivatives JANSSEN PHARMACEUTICA NV (BE) 2015-11-17 US disclosed
US-20140378701-A1 PROCESS FOR THE PREPARATION OF PROTECTED L-ALANINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2014-12-25 US disclosed
US-20140343279-A1 PROCESS FOR THE PREPARATION OF HISTAMINE H3 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-11-20 US disclosed
US-8748596-B2 Process for the preparation of histamine H3 receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2014-06-10 US disclosed
US-20130066055-A1 NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-03-14 US disclosed
US-20110105762-A1 TOTAL SYNTHESIS OF SALINOSPORAMIDE A AND ANALOGS THEREOF NEREUS PHARMACEUTICALS, INC. (US) 2011-05-05 US disclosed
EP-0519496-B1 Thermosetting copolymers, silicon carbide-based fiber and processes for producing same TONEN CORP (JP) 1996-05-22 EP disclosed
EP-0404503-B1 Boron-containing, silicon nitride-based ceramic shaped body production process TONEN CORP (JP) 1996-03-06 EP disclosed
EP-0389084-B1 Process for producing a polyborosilazane TONEN CORP (JP) 1995-09-20 EP disclosed
US-5292830-A Silane, silazane, boron block crosslinked copolymers TONEN CORPORATION (JP) 1994-03-08 US disclosed
EP-0519496-A1 Thermosetting copolymers, silicon carbide-based fiber and processes for producing same Tonen Corporation (JP) 1992-12-23 EP disclosed
US-5128286-A BORON-CONTAINING, SILICON NITRIDE-BASED CERAMIC SHAPED BODY TONEN CORPORATION (JP) 1992-07-07 US disclosed
US-5030744-A Polyborosilazane and process for producing same TONEN CORPORATION (JP) 1991-07-09 US disclosed
EP-0404503-A1 Boron-containing, silicon nitride-based ceramic shaped body production process Tonen Corporation (JP) 1990-12-27 EP disclosed
EP-0389084-A2 Process for producing a polyborosilazane Tonen Corporation (JP) 1990-09-26 EP disclosed